FARMINGTON HILLS, Mich., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment...
Merger completed with Rexahn Pharmace u ticals c reat ing a Nasdaq-listed Biopharmaceutical Company Focused on Advancing Ocuphire’s Late-Stage Clinical Pipeline of Ophthalmic Drug Candidates
ROCKVILLE, Md., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NASDAQ:REXN) (“Rexahn”) announced today that the merger transaction between Rexahn and Ocuphire Pharma, Inc. is expected...
ROCKVILLE, Md., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NASDAQ:REXN) (“Rexahn”) announced today that at its special meeting of stockholders held on November 2, 2020, Rexahn’s...
NEW YORK, NY / ACCESSWIRE / August 22, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Majesco (NASDAQ:MJCO) concerning potential violations of the federal securities laws...
NEW YORK, NY / ACCESSWIRE / July 25, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Rexahn Pharmaceuticals, Inc. (NASDAQ:REXN) concerning potential violations of the federal...
SHAREHOLDER ALERT: Halper Sadeh LLP is Investigating Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - MXIM, BFYT, ADSW, REXN NEW YORK, NY / ACCESSWIRE...
NEW YORK, July 21, 2020 (GLOBE NEWSWIRE) --
NEW YORK, NY / ACCESSWIRE / July 18, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the following mergers are fair to shareholders. Halper Sadeh LLP may seek increased...
NEW YORK, NY / ACCESSWIRE / July 14, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the following mergers are fair to shareholders. Halper Sadeh LLP may seek increased...